Accomplished Senior Medical Director at Parexel International with expertise in global Phase I–III trial leadership and risk assessment. Proven track record in cell and gene therapy strategy, mentoring teams, and achieving zero critical audit findings. Adept at client engagement and driving innovative research, with over 30 peer-reviewed publications.
Hematology‑Oncology, China, 2015
Citizenship: U.S. Citizen